Cargando…
CLEAR Serenity Trial: More Clarity for the Future of Bempedoic Acid in Patients Unable to Take Statins?
See Article by Laufs et al
Autores principales: | Jia, Xiaoming, Virani, Salim S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509702/ https://www.ncbi.nlm.nih.gov/pubmed/30922156 http://dx.doi.org/10.1161/JAHA.119.012352 |
Ejemplares similares
-
Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance
por: Laufs, Ulrich, et al.
Publicado: (2019) -
Statins in COVID-19 infection: A rehash of old themes or truly a new hope?
por: Jia, Xiaoming, et al.
Publicado: (2021) -
Statins and Bempedoic Acid: Different Actions of Cholesterol Inhibitors on Macrophage Activation
por: Linnenberger, Rebecca, et al.
Publicado: (2021) -
Bempedoic Acid, an Inhibitor of Cholesterol Biosynthesis, Reduces Cardiovascular Events
por: Jialal, Ishwarlal, et al.
Publicado: (2023) -
Bempedoic acid for the treatment of dyslipidemia
por: Marrs, Joel C, et al.
Publicado: (2020)